Hepatitis C virus coinfection independently increases the risk of cardiovascular disease in HIV-positive patients

Journal of Viral Hepatitis

Volumn 23, Issue 1, 2016, Pages 47-52

  Fernandez Montero J V ^a   Barreiro, P ^b   De Mendoza, C ^c   Labarga, P ^d   Soriano, V ^b  

^a CROSSHOUSE HOSPITAL   (United Kingdom)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^c HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^d La Luz Clinic ^*  (Spain)

Author keywords

antiretroviral therapy; cardiovascular disease; coinfection; hepatitis C; HIV

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ANGINA PECTORIS; ARTICLE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CHRONIC HEPATITIS C; CONTROLLED STUDY; DEATH; DEMOGRAPHY; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; INCIDENCE; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SMOKING; CARDIOVASCULAR DISEASES; COMPLICATION; HEPACIVIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; LIVER CIRRHOSIS; PATHOLOGY; VIROLOGY;

ADULT; CARDIOVASCULAR DISEASES; COINFECTION; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HIV INFECTIONS; HIV-1; HUMANS; LIVER CIRRHOSIS; MALE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84954078274     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/jvh.12447     Document Type: Article

References (38)

1. Smith C, Ryom L, Weber R, et al,. Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration. Lancet 2014; 384: 241-248
2. Costagliola D,. Demographics of HIV and aging. Curr Opin HIV AIDS 2014; 9: 294-301
3. Samji H, Cescon A, Hogg R, et al,. North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA. Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PLoS ONE 2013; 8: e81355
4. Soriano V, Vispo E, Fernandez-Montero JV, Labarga P, Barreiro P,. Update on HIV/HCV coinfection. Curr HIV/AIDS Rep 2013; 10: 226-234
5. Cacoub P, Gragnani L, Comarmond C, et al,. Extrahepatic manifestations of chronic hepatitis C virus infection. Dig Liver Dis 2014; 46 (Suppl. 5): 165-173
6. Lee M, Yang H, Lu S, et al,. Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: a community-based long-term prospective study. J Infect Dis 2012; 206: 469-477
7. Peveling-Oberhag J, Arcaini L, Hansmann ML, Zeuzem S,. Hepatitis C-associated B-cell non-Hodgkinlymphomas. Epidemiology, molecular signature and clinical management. J Hepatol 2013; 59: 169-177
8. Su F, Su C, Chang S, et al,. Association of hepatitis C virus infection with risk of ESRD: a population-based study. Am J Kidney Dis 2012; 60: 553-560
9. Butt A, Xiaoqiang W, Budoff M, et al,. Hepatitis C virus infection and the risk of coronary disease. Clin Infect Dis 2009; 49: 225-232
10. Pothineni N, Delongchamp R, Vallurupalli S, et al,. Impact of hepatitis C seropositivity on the risk of coronary heart disease events. Am J Cardiol 2014; 114: 1841-1845
11. Lee M, Yang H, Wang C, et al,. Hepatitis C virus infection and increased risk of cerebrovascular disease. Stroke 2010; 41: 2894-2900
12. Liao C, Su T, Sung F, et al,. Does hepatitis C virus infection increases the risk for stroke? A population-based cohort study PLoS ONE 2012; 7: e31527
13. Virgin H, Wherry EJ, Ahmed R,. Redefining chronic viral infection. Cell 2009; 138: 30-50
14. Fernández-Montero JV, Vispo E, Barreiro P, et al,. Hepatitis delta is a major determinant of liver decompensation events and death in HIV-infected patients. Clin Infect Dis 2014; 58: 1549-1553
15. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. Available at http://aidsinfo.nih.gov/ContentFiles/ Adultand AdolescentGL.pdf. [Last accessed 2/7/2015]
16. Adinolfi L, Restivo L, Zampino R, et al,. Chronic HCV infection is a risk of atherosclerosis-role of HCV and HCV-related steatosis. Atherosclerosis 2012; 221: 496-502
17. Petta S, Torres D, Fazio G, et al,. Carotid atherosclerosis and chronic hepatitis C: a prospective study of risk associations. Hepatology 2012; 55: 1317-1323
18. Fedele F, Bruno N, Mancone M,. Cardiovascular risk factors and HIV disease. AIDS Rev 2011; 13: 119-129
19. Lõpez M, San Román J, Estrada V, Vispo E, Blanco F, Soriano V,. Endothelial dysfunction in HIV infection-the role of circulating endothelial cells, microparticles, endothelial progenitor cells and macrophages. AIDS Rev 2012; 14: 223-230
20. Lõpez M, Vispo E, San Román J, et al,. High risk of endothelial dysfunction in HIV individuals may result from deregulation of circulating endothelial cells and endothelial progenitor cells. AIDS Res Hum Retroviruses 2012; 28: 656-659
21. Lõpez M, San Román J, Estrada V, Vispo E, Soriano V,. Cardiovascular disease risk in HIV infection and endothelial progenitor cells. J Infect Dis 2012; 206: 1479-1480
22. Wiest R, Lawson M, Geuking M,. Pathological bacterial translocation in liver cirrhosis. J Hepatol 2014; 60: 197-209
23. Peters L, Neuhaus J, Duprez D, et al,. Biomarkers of inflammation, coagulation and microbial translocation in HIV/HCV co-infected patients in the SMART study. J Clin Virol 2014; 60: 295-300
24. Freiberg M, Chen D, Kraemer K, et al., The association between hepatitis C infection and prevalent cardiovascular disease among HIV-infected individuals. AIDS 2007; 21: 193-197
25. Bedimo R, Westfall A, Mugavero M, et al,. Hepatitis C virus coinfection and the risk of cardiovascular disease among HIV-infected patients. HIV Med 2010; 11: 462-468
26. Gillis J, Smieja M, Cescon A, et al,. Risk of cardiovascular disease associated with HCV and HBV coinfection among antiretroviral-treated HIV-infected individuals. Antivir Ther 2014; 19: 309-317
27. Weber R, Sabin C, Reiss P,. HBV or HCV coinfections and risk of myocardial infarction in HIV-infected individuals: the D:A: D Cohort Study. Antivir Ther 2010; 15: 1077-1086
28. Innes H, McDonald S, Dillon J, et al., Towards a more complete understanding of the association between a hepatitis C sustained viral response and cause-specific outcomes. Hepatology 2015; 62; 355-364
29. Van der Meer A, Veldt B, Feld J, et al,. Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis. JAMA 2012; 308: 2584-2593
30. Smith-Palmer J, Cerri K, Valentine W,. Achieving sustained virological response in hepatitis C: a systematic review of the clinical, economic and quality of life benefits. BMC Infect Dis 2015; 15: 19
31. Shiffman M, Benhamou Y,. Cure of HCV related liver disease. Liver Int 2015; 35 (Suppl. 1): 71-77
32. McCombs J, Matsuda T, Tonnu-Mihara I, et al,. The risk of long-term morbidity and mortality in patients with chronic hepatitis C: results from an analysis of data from a Department of Veterans Affairs Clinical Registry. JAMA Intern Med 2014; 174: 204-212
33. Hsu Y, Ho H, Huang Y, et al,. Association between antiviral treatment and extrahepatic outcomes in patients with hepatitis C virus infection. Gut 2015; 64: 495-503
34. Soriano V, Labarga P, Fernandez-Montero JV, et al,. Hepatitis C cure with antiviral therapy-benefits beyond the liver. Antivir Ther 2015; doi: 10.3851/IMP2975. [Epub ahead of print]
35. Berenguer J, Rodriguez E, Miralles P, et al,. Sustained virological response to interferon plus ribavirin reduces non-liver-related mortality in patients with HIV and hepatitis C virus. Clin Infect Dis 2012; 55: 728-36
36. Labarga P, Fernández-Montero JV, de Mendoza C, et al,. Long-term survival and liver-related events after pegylated interferon/ribavirin therapy in HIV-infected patients with chronic hepatitis C. Antiviral Ther 2015; 20: 65-72
37. Soriano V, Berenguer J,. Extrahepatic comorbidities associated with hepatitis C virus in HIV-infected patients. Curr Opin HIV AIDS 2015; 10: 309-315
38. Chew K, Hua L, Bhattacharya D, Butt A, et al., The effect of hepatitis C virologic clearance on cardiovascular disease biomarkers in HIV/HCV coinfection. Open Forum Infect Dis 2014; 1: ofu104